Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/21/2015 01/22/2015 01/23/2015 01/26/2015 01/27/2015 Date
61.95(c) 62.09(c) 62.07(c) 62.46(c) 61.99 Last
4 943 054 9 247 516 3 741 340 4 908 414 7 767 730 Volume
-0.80% +0.23% -0.03% +0.63% -0.75% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
01/27Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 684 M
EBIT 2014 3 376 M
Net income 2014 2 355 M
Finance 2014 1 273 M
Yield 2014 2,31%
Sales 2015 15 605 M
EBIT 2015 3 164 M
Net income 2015 2 621 M
Finance 2015 1 298 M
Yield 2015 2,36%
PER 2014 44,44
PER 2015 38,16
EV / Sales 2014 6,52x
EV / Sales 2015 6,56x
Capitalization 103 607 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
05:35p U.S. multinationals hit hard by strong dollar, to bleed further into 2015
02:04pDJBristol-Myers Sales Boosted by Cancer Drugs -- Update
08:41a BRISTOL MYERS SQUIBB : Results of Operations and Financial Condition, Financial ..
07:51a BRISTOL MYERS SQUIBB : Pension charge, lower sales slash Bristol-Myers' Q4 profi..
07:50a BRISTOL MYERS SQUIBB : Appoints Giovanni Caforio, M.D., Chief Executive Officer,..
07:47aDJBristol-Myers Sales Boosted by Cancer Drugs
07:31a BRISTOL MYERS SQUIBB : Reports Fourth Quarter and Full Year 2014 Financial Resul..
01:35a BRISTOL MYERS SQUIBB : Makes Leadership Changes
More news
Sector news Pharmaceuticals - NEC
05:35p U.S. multinationals hit hard by strong dollar, to bleed further into 2015
05:23pDJADR Shares End Mixed; Philips Shares Drop
05:13p AMGEN : profit tops expectations on Enbrel sales, tax credit
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF